Blog

Oct 2, 2024, 13:33

JAMA Oncology – IMRT shows improved safety for locally advanced NSCLC

JAMA Oncology shared on X:

”Improvements in radiation using IMRT translated into less pneumonitis for locally-advanced NSCLC in NRG Oncology-RTOG 0617 compared to 3D-CRT. Planning should minimize the heart V40Gy and lung V20Gy, as the lung V5Gy had no long-term impact on outcome.”

Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer.

Authors: Stephen G. Chun, Chen Hu, Ritsuko U. Komaki, Robert D. Timmerman, Steven E. Schild, Jeffrey A. Bogart, Michael C. Dobelbower, Walter Bosch, Vivek S. Kavadi, Samir Narayan, Puneeth Iyengar, Clifford Robinson, Jan Rothman, Adam Raben, Mark E. Augspurger, Robert M. MacRae, Rebecca Paulus, Jeffrey D. Bradley.

JAMA Oncology - IMRT shows improved safety for locally advanced NSCLC

Source: JAMA Oncology/X

Adam Raben cancer Chen Hu Clifford Robinson IMRT JAMA Oncology Jan Rothman Jeffrey A. Bogart Jeffrey D. Bradley Mark E. Augspurger Michael C. Dobelbower NRG Oncology OncoDaily Oncology Puneeth Iyengar Rebecca Paulus Ritsuko U. Komaki Robert D. Timmerman Robert M. MacRae Samir Narayan Stephen G. Chun Steven E. Schild Vivek S. Kavadi Walter Bosch

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage